Login / Signup
Natalizumab safety in paediatric-onset multiple sclerosis at the time of SARS-Cov-2 pandemic.
Monica Margoni
Paolo Gallo
Published in:
Multiple sclerosis journal - experimental, translational and clinical (2020)
Keyphrases
</>
sars cov
multiple sclerosis
respiratory syndrome coronavirus
intensive care unit
white matter
emergency department